June Chang

Boston Scientific Corporation (NYSE: BSX) transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, the company advances science for life by providing a broad range of high performance solutions that address unmet patient needs and improve the efficiency of healthcare. Boston Scientific was founded in June 1979 by John Abele and Pete Nicholas in the United States. In May 1992, the company was successfully listed on the New York Stock Exchange. After more than 40 years of development, Boston Scientific now has a market presence in over 120 countries and regions worldwide. Headquartered in Shanghai, Boston Scientific Greater China adheres to an innovative mindset and caring culture, integrating global resources and local perspective to provide effective healthcare solutions. The company strives to become the most innovative medical technology company that is custom-tailored to fit the needs of Chinese physicians and patients. Boston Scientific commits to advancing science for life and striving for a Healthy China. The core businesses of Boston Scientific in Greater China include: interventional cardiology, structural heart, cardiac rhythm management and electrophysiology, endoscopy, peripheral interventions and oncology, respiratory interventions, urology and pelvic health etc. Boston Scientific Greater China is promoting a corporate culture of innovation and caring. It is striving to build an energetic and efficient globally leading medical technology company through involving every employee. By being fast in speed, by adhering to excellent standards, by having a resilient grit and perseverant willpower, and by adopting a broad vision for collaboration, the company is committed to learn and meet the medical needs of the patients, thereby ensuring to provide high-quality healthcare solutions for them.